With next-generation metabolic combinations continuing to set new standards in the clinic, type 2 diabetes and chronic weight management have now entered an unprecedented therapeutic era.

Eli Lilly delivered strong Q2/26 results with 47.7% revenue growth and raised full-year revenue guidance, yet EPS guidance was slightly trimmed. Learn more about LLY stock here.

Eli Lilly (LLY) just expanded its collaboration with Gate Bioscience to pursue additional molecular gate therapeutics, a research heavy area that often attracts long-horizon investors who focus on pipelines rather than near term swings. Eli Lilly’s share price has cooled in recent months, with a 7-day share price return of 3.52% down and a 90-day share price return of 7.48% down, even as the 1-year total shareholder return sits at 36.13% and the 5-year total shareholder return at 411.92%,...

Eli Lilly (NYSE:LLY) stock is in focus as its oral obesity pill and expanding incretin pipeline anchor fresh healthcare-sector headlines today.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Eli Lilly is partnering with Ginkgo Bioworks on drug discovery.

Eli Lilly is partnering with Ginkgo Bioworks on drug discovery.

Las acciones de Eli Lilly (LLY:NYSE) cotizaban a alrededor de 1.162 dólares el lunes 5 de octubre, después de que Gate Bioscience dijera que había ampliado su acuerdo de descubrimiento de fármacos con Lilly en un acuerdo con un valor potencial de más de 870 millones de dólares. Es el segundo acuerdo de Lilly con la biotecnología privada en unos 15 meses, después de un acuerdo de julio de 2025 por un valor de hasta 856 millones de dólares.

Eli Lilly first linked up with Gate Bioscience in July 2025 to leverage the biotech’s “Molecular Gate” engine to treat diseases with high unmet need. Monday’s expansion will add one undisclosed target to the existing agreement, with an option for a second.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets

Q2 revenue reached USD 22.97 billion, up 47.70 percent year over year. Eli Lilly stock costs EUR 1,0

Former Miss Universe and Actor Lara Dutta lends her voice to encourage conversations on memory and cognitive health. An estimated 8.8 million adults aged 60 years and older in India are living with dementia1,2, with Alzheimer’s disease being its most common form